Clinical Evaluation of the RAVI-Guide
NCT02196584 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2016-06-23
Summary
Hypothesis: The RAVI-Guide provides superior patient acceptability to the conventional lid speculum during intravitreal injections
Aims: To compare patient acceptance and procedural complication rates of the RAVI-Guide with those of the conventional lid speculum and caliper approach
Conditions
Sponsors & Collaborators
-
Medical College of Wisconsin
lead OTHER
Principal Investigators
-
Dennis P Han, MD · Medical College of Wisconsin
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-08-31
- Primary Completion
- 2015-09-30
- Completion
- 2016-06-30
Countries
- United States
Study Locations
More Related Trials
-
Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration
NCT01014468 ·Status: UNKNOWN ·Phase: PHASE3
-
Ranibizumab for Myopic Neovascularization
NCT01246089 ·Status: UNKNOWN ·Phase: PHASE4
-
Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations
NCT00831350 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
NCT02510794 ·Status: COMPLETED ·Phase: PHASE2
-
Scotoma Reduction in AMD Patients Treated With Ranibizumab
NCT00467935 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intravitreal Injections-related Anxiety
NCT02035722 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis
NCT00804934 ·Status: COMPLETED
-
Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration
NCT01780935 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization
NCT00436553 ·Status: COMPLETED ·Phase: PHASE3
-
Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retinopathy
NCT06173245 ·Status: COMPLETED ·Phase: NA
-
A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis
NCT00404612 ·Status: COMPLETED ·Phase: PHASE3
-
Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration
NCT00764738 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.
NCT02321839 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.
NCT01942213 ·Status: COMPLETED
-
Study EvAluating Genotypes While Using Lucentis 2
NCT01464723 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration
NCT00813891 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab
NCT00559715 ·Status: UNKNOWN ·Phase: PHASE3
-
Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD
NCT01269151 ·Status: COMPLETED ·Phase: NA
-
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab
NCT01402544 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia
NCT03409250 ·Status: COMPLETED ·Phase: PHASE4
-
Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion
NCT01710839 ·Status: COMPLETED ·Phase: PHASE4
-
Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion
NCT02169648 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION)
NCT06460844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Accuracy of Home Monitoring for Acute Macular Degeneration (AMD) Disease Activity
NCT02304068 ·Status: COMPLETED ·Phase: NA
-
Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration
NCT00967213 ·Status: COMPLETED ·Phase: PHASE3